HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 104/3/579    most recent 01091.2007v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kollias, H. D. Articles by McDermott, J. C. Search for Related Content PubMed PubMed Citation Articles by Kollias, H. D. Articles by McDermott, J. C.

INVITED REVIEWS

Transforming growth factor-β and myostatin signaling in skeletal muscle

¹Department of Neurology, Johns Hopkins Hospital, Baltimore, Maryland; and ²Department of Biology, York University, Toronto, Ontario, Canada

The superfamily of transforming growth factor-β (TGF-β) cytokines has been shown to have profound effects on cellular proliferation, differentiation, and growth. Recently, there have been major advances in our understanding of the signaling pathway(s) conveying TGF-β signals to the nucleus to ultimately control gene expression. One tissue that is potently influenced by TGF-β superfamily signaling is skeletal muscle. Skeletal muscle ontogeny and postnatal physiology have proven to be exquisitely sensitive to the TGF-β superfamily cytokine milieu in various animal systems from mice to humans. Recently, major strides have been made in understanding the role of TGF-β and its closely related family member, myostatin, in these processes. In this overview, we will review recent advances in our understanding of the TGF-β and myostatin signaling pathways and, in particular, focus on the implications of this signaling pathway for skeletal muscle development, physiology, and pathology.

myogenesis; Smad; MyoD

This article has been cited by other articles:

				N. K. LeBrasseur, T. M. Schelhorn, B. L. Bernardo, P. G. Cosgrove, P. M. Loria, and T. A. Brown Myostatin Inhibition Enhances the Effects of Exercise on Performance and Metabolic Outcomes in Aged Mice J Gerontol A Biol Sci Med Sci, September 1, 2009; 64A(9): 940 - 948. [Abstract] [Full Text] [PDF]

				C. Alexanderson, E. Eriksson, E. Stener-Victorin, M. Lonn, and A. Holmang Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle J. Endocrinol., April 1, 2009; 201(1): 49 - 58. [Abstract] [Full Text] [PDF]

				M. S. Jaramillo, C. V. Lovato, E. M. Baca, and R. M. Cripps Crossveinless and the TGF{beta} pathway regulate fiber number in the Drosophila adult jump muscle Development, April 1, 2009; 136(7): 1105 - 1113. [Abstract] [Full Text] [PDF]

				F. F. Rose Jr, V. B. Mattis, H. Rindt, and C. L. Lorson Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy Hum. Mol. Genet., March 15, 2009; 18(6): 997 - 1005. [Abstract] [Full Text] [PDF]

				T. A. Souza, X. Chen, Y. Guo, P. Sava, J. Zhang, J. J. Hill, P. J. Yaworsky, and Y. Qiu Proteomic Identification and Functional Validation of Activins and Bone Morphogenetic Protein 11 as Candidate Novel Muscle Mass Regulators Mol. Endocrinol., December 1, 2008; 22(12): 2689 - 2702. [Abstract] [Full Text] [PDF]